In this week's video, Dr. Brian Durie the pros and cons of an autologous stem cell transplant (ASCT).

Bottom line:

It is rare to become worse after ASCT, and its likely benefits need to be evaluated on a long-term basis.

Previous Post
#AskDrDurie: Will any of the newly FDA-approved drugs be available for frontline therapy?
Next Post
What are the best scans to monitor myeloma?

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.